Back to search
FDAFDA · Food and drugs·Recall number D-199-2013

PULMICORT RESPULES 0.5 mg/2 ml (30 ampules/carton) Budesonide Inhalation Suspension NDC: 0186-1989-04

Published March 20, 2013 · Recall initiated: January 11, 2013

Summary

FDA records drug Class III recall D-199-2013, published March 20, 2013 and initiated January 11, 2013. Recalling firm: AstraZeneca LP; Status: Terminated; Reported quantity: 64675 cartons; Lot: Lot/Exp Date: YP0035 11/13; YP0140 12/13; YP0136 12/13; AB0077 2/14; AH0133 5/14. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Does Not Meet Monograph: Budesonide may be slightly above or below the specification range.

What to do

Voluntary: Firm initiated · Letter

Get an email if PULMICORT RESPULES has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PULMICORT RESPULES
Manufacturer
AstraZeneca LP
Distributor
Nationwide
Lot
Lot/Exp Date: YP0035 11/13; YP0140 12/13; YP0136 12/13; AB0077 2/14; AH0133 5/14
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PULMICORT RESPULES 0.5 mg/2 ml (30 ampules/carton) Budesonide Inhalation Suspension NDC: 0186-1989-04 recalled?

Yes. FDA published recall D-199-2013 on March 20, 2013. Reported hazard: Does Not Meet Monograph: Budesonide may be slightly above or below the specification range.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PULMICORT RESPULES.